Overview
Cervical carcinoma is a malignant cancer arising in the cervix, the lower, narrow portion of the uterus. It is among the most common gynaecological cancers worldwide and is strongly associated with persistent infection by high-risk human papillomavirus (HPV). Because precancerous changes can be detected early through Pap smear screening and HPV testing, and because vaccination can prevent the causative infection, cervical carcinoma is considered largely preventable, yet it remains a major cause of cancer death in regions with limited access to screening. Treatment depends on stage and may include surgery, radiation therapy, brachytherapy, and chemotherapy. Research published in the International Journal of Chemotherapy Research and Practice and related OpenAccessPub titles addresses several facets of this disease: a study of cervical cancer characterised by an active and stable PI3K/mTOR/AKT signalling pathway in patients from Azerbaijan examines molecular drivers relevant to targeted therapy, while a retrospective case-control study compares two-dimensional and three-dimensional brachytherapy approaches for survival outcomes in cervical cancer. These studies reflect the journal's focus on cancer treatment and chemotherapeutic practice. This page gathers peer-reviewed, open-access research relevant to cervical carcinoma and its management.
Research published in this journal
4 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 4 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Journal of New Developments in Chemistry
-
2025 · Journal of new developments in Chemistry
-
2020 · International Journal of Human and Health Sciences (IJHHS)
-
Siti Mariam Ja’afar et al. · 2020 ·
A sample of recent works citing this journal's research on Cervical Carcinoma, linking to each citing work.